| The evolving field of human papillomavirus receptor research: a review of binding and entry AB Raff, AW Woodham, LM Raff, JG Skeate, L Yan, DM Da Silva, ... Journal of virology 87 (11), 6062-6072, 2013 | 239 | 2013 |
| Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro MP Rudolf, SC Fausch, DM Da Silva, WM Kast The Journal of Immunology 166 (10), 5917-5924, 2001 | 223 | 2001 |
| Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses SC Fausch, DM Da Silva, MP Rudolf, WM Kast The Journal of Immunology 169 (6), 3242-3249, 2002 | 209 | 2002 |
| The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection AW Woodham, DM Da Silva, JG Skeate, AB Raff, MR Ambroso, HE Brand, ... PloS one 7 (8), e43519, 2012 | 192 | 2012 |
| Cervical cancer vaccines: emerging concepts and developments DM Da Silva, GL Eiben, SC Fausch, MT Wakabayashi, MP Rudolf, ... Journal of cellular physiology 186 (2), 169-182, 2001 | 167 | 2001 |
| Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells SC Fausch, DM Da Silva, WM Kast Cancer Research 63 (13), 3478-3482, 2003 | 162 | 2003 |
| Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation SC Fausch, LM Fahey, DM Da Silva, WM Kast The Journal of Immunology 174 (11), 7172-7178, 2005 | 128 | 2005 |
| Cervical cancer vaccines: recent advances in HPV research GL Eiben, DM Da Silva, SC Fausch, IC Le Poole, MI Nishimura, WM Kast Viral immunology 16 (2), 111-121, 2003 | 111 | 2003 |
| Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines DM Da Silva, DV Pastrana, JT Schiller, WM Kast Virology 290 (2), 350-360, 2001 | 109 | 2001 |
| Chimeric papillomavirus virus‐like particles induce a murine self‐antigen‐specific protective and therapeutic antitumor immune response JD Nieland, DM Da Silva, MP Velders, KE de Visser, JT Schiller, M Müller, ... Journal of cellular biochemistry 73 (2), 145-152, 1999 | 106 | 1999 |
| Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesions S Kanodia, DM Da Silva, WM Kast International journal of cancer 122 (2), 247-259, 2008 | 102 | 2008 |
| Physical interaction of human papillomavirus virus-like particles with immune cells DM Da Silva, MP Velders, JD Nieland, JT Schiller, BJ Nickoloff, WM Kast International immunology 13 (5), 633-641, 2001 | 101 | 2001 |
| Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases JG Skeate, AW Woodham, MH Einstein, DM Da Silva, WM Kast Human vaccines & immunotherapeutics 12 (6), 1418-1429, 2016 | 97 | 2016 |
| Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines DM Da Silva, JT Schiller, WM Kast Vaccine 21 (23), 3219-3227, 2003 | 89 | 2003 |
| Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcγ receptors and contributes to acquisition of T cell immunity DM Da Silva, SC Fausch, JS Verbeek, WM Kast The Journal of Immunology 178 (12), 7587-7597, 2007 | 88 | 2007 |
| Uptake of Human Papillomavirus Virus-Like Particles by Dendritic Cells Is Mediated by Fc Receptors and Contributes to Acquisition of T Cell Immunity DM Da Silva, SC Fausch, JS Verbeek, WM Kast immunity 23, 25, 2007 | 88* | 2007 |
| Human immunodeficiency virus immune cell receptors, coreceptors, and cofactors: implications for prevention and treatment AW Woodham, JG Skeate, AM Sanna, JR Taylor, DM Da Silva, ... AIDS patient care and STDs 30 (7), 291-306, 2016 | 74 | 2016 |
| Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer JS Mayadev, D Enserro, YG Lin, DM Da Silva, HA Lankes, C Aghajanian, ... JAMA oncology 6 (1), 92-99, 2020 | 73 | 2020 |
| Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16 LM Fahey, AB Raff, DM Da Silva, WM Kast The Journal of Immunology 182 (5), 2919-2928, 2009 | 69 | 2009 |
| A major role for the minor capsid protein of human papillomavirus type 16 in immune escape LM Fahey, AB Raff, DM Da Silva, WM Kast The Journal of Immunology 183 (10), 6151-6156, 2009 | 68 | 2009 |
